{"slideshow_credits": null, "snippet": "About 10 drugs are now approved to treat multiple sclerosis, and their prices are rising sharply. The generic Copaxone could help keep prices of all the drugs in check.", "abstract": "Food and Drug Admin approves first generic substitute for multiple sclerosis drug Copaxone, the biggest-selling product for Teva Pharmaceutical Industries; generic, developed by Sandoz and Momenta Pharmaceuticals, could introduce competition for drug that costs some $60,000 per year.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/04/17/business/generic-version-of-copaxone-multiple-sclerosis-drug-is-approved.html", "lead_paragraph": "About 10 drugs are now approved to treat multiple sclerosis, and their prices are rising sharply. The generic Copaxone could help keep prices of all the drugs in check.", "headline": {"main": "Generic Version of Copaxone, Multiple Sclerosis Drug, Is Approved", "print_headline": "Generic Version of Copaxone, Multiple Sclerosis Drug, Is Approved"}, "_id": "5530051838f0d847eef0f488", "word_count": "862", "multimedia": [], "pub_date": "2015-04-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Multiple Sclerosis", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Generic Brands and Products", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Momenta Pharmaceuticals Inc", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Sandoz International GmbH", "is_major": "Y", "rank": "5"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "6"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}